Cargando…
Initiation of prostate cancer in mice by Tp53(R270H): evidence for an alternative molecular progression
Tp53 mutations are common in human prostate cancer (CaP), occurring with a frequency of ∼30% and ∼70% in localized and metastatic disease, respectively. In vitro studies have determined several common mutations of Tp53 that have specific gain-of-function properties in addition to loss of function, i...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Company of Biologists Limited
2012
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3484872/ https://www.ncbi.nlm.nih.gov/pubmed/22563073 http://dx.doi.org/10.1242/dmm.008995 |